Heineken warns British pubs weight-loss drugs could curb drinks sales
Heineken has advised British pubs to promote smaller drinks, alcohol-free options and snacks as weight-loss drugs become more popular and could curb beer and cider sales.
Review information is loading.
Heineken is urging British pubs to adapt to the growing popularity of weight-loss drugs, warning that customers taking them may buy less beer and cider. The brewer recommends promoting smaller servings, low- or no-alcohol drinks and beverages paired with small snacks.
The advice appears in a presentation circulated this month and seen by Reuters, according to an ANP report. Heineken says the drugs pose a risk to on-trade beer sales because they can make people feel full sooner, reducing the likelihood of ordering several drinks.
The presentation responds to rising use of medicines based on GLP-1 agonists, including Ozempic and Wegovy. Heineken’s proposed changes are intended to help pubs offset any decline in demand; the report does not quantify the potential effect on sales.
Sign in to give this article a thumbs up or down.
About this discussion and AI questions
Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.
Sign in with a confirmed reader account and choose a username to read comments and participate.
Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.
Loading comments…